New approach aims to make fibroid surgery safer by cutting blood loss
NCT ID NCT07390864
Summary
This study aims to find which of two drugs works better to reduce bleeding when injected into the uterus wall during surgery to remove fibroids. Researchers will compare ergometrine and carbetocin in 40 women undergoing this specific operation. The goal is to see which drug better controls blood loss during and after surgery, potentially lowering the need for blood transfusions and improving recovery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOMA;UTERUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fayoum University
RECRUITINGAl Fayyum, Faiyum Governorate, 38521, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.